An evaluation of pharmacy prescribing in Northern Ireland-a quantitative and qualitative assessment (PDF 62KB)

Independent research jointly commissioned by the Department of Health, Social Services and Public Safety (DHSSPS) and the HSC R&D Division.

Improving Patients' Access to Medicines: A Guide to Implementing Nurse and Pharmacist Independent Prescribing within the HPSS in Northern Ireland (PDF 704 KB)

A Guide to Implementing Nurse and Pharmacist Independent Prescribing within the HPSS in Northern Ireland

Best Practice Guidance for Supplementary Prescribing by Nurses Within the HPSS in Northern Ireland (PDF 270 KB)

Provides clear information on the practical implementation of supplementary prescribing.

Supplementary Prescribing by Nurses and Pharmacists (PDF 413 KB)

Supplementary Prescribing by Nurses and Pharmacists

Extending Independent Nurse Prescribing (PDF 306 KB)

Extending Independent Nurse Prescribing Within the HPSS in N.I.

Drug Problems - Can Substitute Prescribing Services Help You? Leaflet

Drug Problems - Can Substitute Prescribing Services Help You? Leaflet

Evidence Base to Inform the Operational Arrangements for the Proposed Prescribing and Supply of Specialist Medicines

Executive Summary

Appropriateness and long-term discontinuation rate of biological therapies in ulcerative colitis.

BACKGROUND: Anti-TNFα agents are commonly used for ulcerative colitis (UC) therapy in the event of non-response to conventional strategies or as colon-salvaging therapy. The objectives were to assess the appropriateness of biological therapies for UC patients and to study treatment discontinuation over time, according to appropriateness of treatment, as a measure of outcome. METHODS: We selected adult ulcerative colitis patients from the Swiss IBD cohort who had been treated with anti-TNFα agents. Appropriateness of the first-line anti-TNFα treatment was assessed using detailed criteria developed during the European Panel on the Appropriateness of Therapy for UC. Treatment discontinuation as an outcome was assessed for categories of appropriateness. RESULTS: Appropriateness of the first-line biological treatment was determined in 186 UC patients. For 64% of them, this treatment was considered appropriate. During follow-up, 37% of all patients discontinued biological treatment, 17% specifically because of failure. Time-to-failure of treatment was significantly different among patients on an appropriate biological treatment compared to those for whom the treatment was considered not appropriate (p=0.0007). Discontinuation rate after 2years was 26% compared to 54% between those two groups. Patients on inappropriate biological treatment were more likely to have severe disease, concomitant steroids and/or immunomodulators. They were also consistently more likely to suffer a failure of efficacy and to stop therapy during follow-up. CONCLUSION: Appropriateness of first-line anti-TNFα therapy results in a greater likelihood of continuing with the therapy. In situations where biological treatment is uncertain or inappropriate, physicians should consider other options instead of prescribing anti-TNFα agents.

Northern Ireland Substitute Prescribing Database Report 31 March 2014

This bulletin summarises information on individuals referred to the Northern Ireland Substitute Prescribing Scheme (SPS). It relates to those referred up to and including the 31 March 2014 and focuses on those patients in contact with Substitute Prescribing treatment services during 2013/14.

Antibiotic prescribing resources for health professionals

Antibiotic prescribing resources for health professionals.

Northern Ireland Substitute Prescribing Database Report 31 March 2013

This bulletin summarises information on individuals referred to the Northern Ireland Substitute Prescribing Scheme (SPS). It relates to those referred up to and including the 31 March 2013 and focuses on those patients in contact with Substitute Prescribing treatment services during 2012/13.